Evaluation of Coagulation in Multiple Sclerosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01711255|
Recruitment Status : Completed
First Posted : October 22, 2012
Last Update Posted : July 28, 2017
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||69 participants|
|Official Title:||A Cross-Sectional Study of Coagulation in Multiple Sclerosis|
|Actual Study Start Date :||October 2012|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
Subjects who have been diagnosed with clinically definite or probable multiple sclerosis as defined and recorded by board certified neurologist.
Adults age 18 and older who have not been diagnosed with any neurological, endocrine, or other chronic health condition. They must also be free of any recent acute illness that can impact inflammation/clotting.
- Sonoclot Coagulation Spectrum (Sonoclot Signature) [ Time Frame: Day 1 ]The Sonoclot Coagulation Spectrum represents a combination of coagulation parameters, including activated clotting time, clot rate, time to peak, and peak amplitude. The mean value of all contributing parameters will be compared between cases and controls.
- ASA24 omega-3 fatty acid intake [ Time Frame: 24 hour recall (24 hours prior to study visit) ]The ASA24, in combination with a medication history, will be used to evaluate whether omega-3 fatty acid intake is associated with reduced rates of coagulation in either cases or controls.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01711255
|United States, Washington|
|Bastyr University Clinical Research Center|
|Kenmore, Washington, United States, 98028|
|Principal Investigator:||Laurie K Mischley, ND||Bastyr University - Clinical Research Center|